Pandion Therapeutics Holdco LLC Contracts & Agreements
34 Contracts & Agreements
- Business Finance (7 contracts)
- Business Operations (4)
- Human Resources (11)
- Mergers & Acquisitions (1)
- Real Estate (1)
- Uncategorized (10)
- Description of Securities Registered Under Section 12 of the Exchange Act (Filed With SEC on March 12, 2021)
- Confidential Disclosure-In Agreement, dated as of April 9, 2018, between Pandion Therapeutics, Inc. and Merck Sharp & Dohme Corp (Filed With SEC on March 12, 2021)
- Amendment No. 1 to Confidential Disclosure-In Agreement, dated as of December 16, 2019, between Pandion Therapeutics, Inc. and Merck Sharp & Dohme Corp (Filed With SEC on March 12, 2021)
- Amendment No. 2 to the Confidential Disclosure-In Agreement, dated as of December 18, 2020, between Pandion Therapeutics, Inc. and Merck Sharp & Dohme Corp (Filed With SEC on March 12, 2021)
- Amendment No. 3 to the Confidential Disclosure-In Agreement, dated as of February 13, 2021, between Pandion Therapeutics, Inc. and Merck Sharp & Dohme Corp (Filed With SEC on March 12, 2021)
- Exclusivity Agreement, dated as of February 9, 2021, between Pandion Therapeutics, Inc. and Merck Sharp & Dohme Corp (Filed With SEC on March 12, 2021)
- Agreement and Plan of Merger, dated February 24, 2021, among Pandion Therapeutics, Inc., Merck Sharp & Dohme Corp. and Panama Merger Sub, Inc (Filed With SEC on February 25, 2021)
- Form of Underwriting Agreement (Filed With SEC on July 13, 2020)
- Form of Plan of Conversion (Filed With SEC on July 13, 2020)
- 2020 Stock Incentive Plan (Filed With SEC on July 13, 2020)
- Form of Stock Option Agreement under the 2020 Stock Incentive Plan (Filed With SEC on July 13, 2020)
- Form of Restricted Stock Unit Agreement under the 2020 Stock Incentive Plan (Filed With SEC on July 13, 2020)
- 2020 Employee Stock Purchase Plan (Filed With SEC on July 13, 2020)
- Summary of Non-Employee Director Compensation Policy (Filed With SEC on July 13, 2020)
- License and Collaboration Agreement, dated October 30, 2019, by and between the Registrant and Astellas Pharma Inc (Filed With SEC on July 13, 2020)
- Employment Agreement, dated July 10, 2020, by and between the Registrant and Rahul Kakkar, M.D. (to be effective upon the effective date of the Registration Statement) (Filed With SEC on July 13, 2020)
- Employment Agreement, dated July 10, 2020, by and between the Registrant and Jo Viney, Ph.D. (to be effective upon the effective date of the Registration Statement) (Filed With SEC on July 13, 2020)
- Letter Agreement, dated July 8, 2020, by and between the Registrant and Vikas Goyal (to be effective upon the effective date of the Registration Statement) (Filed With SEC on July 13, 2020)
- Specimen Stock Certificate evidencing the shares of common stock (Filed With SEC on June 26, 2020)
- Amended and Restated Investors Rights Agreement, dated as of March 23, 2020, by and among the Registrant and the other parties thereto (Filed With SEC on June 26, 2020)
- License and Collaboration Agreement, dated October 30, 2019, by and between the Registrant and Astellas Pharma Inc (Filed With SEC on June 26, 2020)
- Antibody Library Subscription Agreement, dated October 11, 2017, by and between the Registrant and Distributed Bio, Inc (Filed With SEC on June 26, 2020)
- Master Services Agreement, dated October 11, 2017, by and between the Registrant and Distributed Bio, Inc (Filed With SEC on June 26, 2020)
- Loan and Security Agreement, dated as of November 8, 2019, by and between Silicon Valley Bank and the Registrant (Filed With SEC on June 26, 2020)
- Warrant issued on November 8, 2019 to Silicon Valley Bank by the Registrant (Filed With SEC on June 26, 2020)
- Lease, dated February 6, 2020, by and between the Registrant and BMR-134 Coolidge Avenue LLC (Filed With SEC on June 26, 2020)
- Offer of Employment, dated July 3, 2019, by and between the Registrant and Rahul Kakkar, M.D (Filed With SEC on June 26, 2020)
- Offer of Employment, dated March 11, 2017, by and between the Registrant and Jo Viney, Ph.D (Filed With SEC on June 26, 2020)
- Offer of Employment, dated July 1, 2019, by and between the Registrant and Vikas Goyal (Filed With SEC on June 26, 2020)
- Offer of Employment, dated May 8, 2017, by and between the Registrant and Anthony Coyle, Ph.D (Filed With SEC on June 26, 2020)
- Letter Agreement, dated July 10, 2019, as amended, by and between the Registration and Anthony Coyle, Ph.D (Filed With SEC on June 26, 2020)
- Consulting Agreement, dated March 27, 2017, by and between the Registrant and Alan Crane (Filed With SEC on June 26, 2020)
- Form of Indemnification Agreement between the Registrant and each of its Executive Officers and Directors (Filed With SEC on June 26, 2020)
- Simple Agreement for Future Equity, dated June 24, 2020, by and between the Registrant and Versant Vantage I, L.P (Filed With SEC on June 26, 2020)